Half Year 2019 Cosmo Pharmaceuticals NV Earnings Call Transcript
Ladies and gentlemen, welcome to the Cosmo Pharmaceuticals Half Year Results Presentation Conference Call. I am Sherry, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to the management team of Cosmo Pharmaceuticals. Please go ahead.
Good morning, everyone. This is Alessandro Della Chà . Thanks for joining this call. Let me quickly walk you through the presentation. Let me tell you that this has been a very rich first half. We have been doing a lot of things. And the first slide and the second slide on the key events, I think, give a very fair representation of the work that has been done in the aftermath of the delay of Methylene Blue MMX. So one of the first things that we have done is that we have announced our revolutionary artificial intelligent product for the detection of lesion during colonoscopy.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |